Annual report
3055.TEDINET S100TUAN
Period2023-04-01 → 2024-03-31
Filed2024-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥275.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥262.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥248.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥239.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥243.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.8bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.5bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.9bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.4bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.7bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.1bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.5bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.2bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥147.3bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥137.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥136.9bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥133.0bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥130.7bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥86.6bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥80.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥60.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥57.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥55.5bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥54.4bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥52.7bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥20.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥20.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥21.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥828m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥898m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥835m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥849m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥731m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥444m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥100.2 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.41 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.44 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.01 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.81 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,819.99 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,614.23 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,460.67 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,346.36 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,239.8 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 41.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.9% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.4% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 3.7% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.8% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,601 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,626 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 1,625 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 1,570 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,485 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥1.6bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥1.9bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.8bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥382m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥712m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥472m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥799m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥289m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥785m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥605m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥337m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.2bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥334m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥1.2bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥619m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥637m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥204m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥44.3bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥44.4bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥44.5bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥44.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥40.3bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.6bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.4bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥42.7bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥42.9bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥42.9bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥43.1bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥40.0bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥15.39 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.36 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.27 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.33 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.7 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥20 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,986.27 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,955.09 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,900.56 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,859.64 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,701.04 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 96.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.8% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.5% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 0.8% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.7% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.4% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 24,400,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 58 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 63 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 62 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 62 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 53 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 103
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2023-04-01 → 2024-03-31 | ¥48m |
| Otherother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥36m |
| Otherother segments | revenue | 2023-04-01 → 2024-03-31 | ¥1.8bn |
| Otherother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥57m |
| Otherother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥1.7bn |
| Otherother segments | segment assets | at 2024-03-31 | ¥44.5bn |
| Otherother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥384m |
| Dispensing Industryreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥144m |
| Dispensing Industryreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥73m |
| Dispensing Industryreportable segment | employees | at 2024-03-31 | 314 pure |
| Dispensing Industryreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥13.3bn |
| Dispensing Industryreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥13.3bn |
| Dispensing Industryreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥12m |
| Dispensing Industryreportable segment | segment assets | at 2024-03-31 | ¥6.3bn |
| Dispensing Industryreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥120m |
| Information And Communication Technology Industryreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥11m |
| Information And Communication Technology Industryreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥25m |
| Information And Communication Technology Industryreportable segment | employees | at 2024-03-31 | 76 pure |
| Information And Communication Technology Industryreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| Information And Communication Technology Industryreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥595m |
| Information And Communication Technology Industryreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥1.0bn |
| Information And Communication Technology Industryreportable segment | segment assets | at 2024-03-31 | ¥858m |
| Information And Communication Technology Industryreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥39m |
| Medical Equipment Wholesale Industryreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥160m |
| Medical Equipment Wholesale Industryreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥221m |
| Medical Equipment Wholesale Industryreportable segment | employees | at 2024-03-31 | 408 pure |
| Medical Equipment Wholesale Industryreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥66.5bn |
| Medical Equipment Wholesale Industryreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥66.0bn |
| Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥527m |
| Medical Equipment Wholesale Industryreportable segment | segment assets | at 2024-03-31 | ¥27.7bn |
| Medical Equipment Wholesale Industryreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.3bn |
| Nursing Industryreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥177m |
| Nursing Industryreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥223m |
| Nursing Industryreportable segment | employees | at 2024-03-31 | 248 pure |
| Nursing Industryreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥4.3bn |
| Nursing Industryreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥4.3bn |
| Nursing Industryreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥8m |
| Nursing Industryreportable segment | segment assets | at 2024-03-31 | ¥5.6bn |
| Nursing Industryreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥326m |
| Wholesaler Of Drugs Industryreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥2.0bn |
| Wholesaler Of Drugs Industryreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥484m |
| Wholesaler Of Drugs Industryreportable segment | employees | at 2024-03-31 | 482 pure |
| Wholesaler Of Drugs Industryreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥199.5bn |
| Wholesaler Of Drugs Industryreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥191.1bn |
| Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥8.4bn |
| Wholesaler Of Drugs Industryreportable segment | segment assets | at 2024-03-31 | ¥98.5bn |
| Wholesaler Of Drugs Industryreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥287.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥275.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥183.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥3.6bn |
| Otherother segments | capex | 2022-04-01 → 2023-03-31 | ¥7m |
| Otherother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥52m |
| Otherother segments | revenue | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| Otherother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥60m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Otherother segments | segment assets | at 2023-03-31 | ¥44.5bn |
| Otherother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥717m |
| Dispensing Industryreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥103m |
| Dispensing Industryreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥88m |
| Dispensing Industryreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥13.5bn |
| Dispensing Industryreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥13.5bn |
| Dispensing Industryreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥12m |
| Dispensing Industryreportable segment | segment assets | at 2023-03-31 | ¥6.3bn |
| Dispensing Industryreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥0 |
| Information And Communication Technology Industryreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥40m |
| Information And Communication Technology Industryreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥21m |
| Information And Communication Technology Industryreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.6bn |
| Information And Communication Technology Industryreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥487m |
| Information And Communication Technology Industryreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Information And Communication Technology Industryreportable segment | segment assets | at 2023-03-31 | ¥813m |
| Information And Communication Technology Industryreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥59m |
| Medical Equipment Wholesale Industryreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥241m |
| Medical Equipment Wholesale Industryreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥229m |
| Medical Equipment Wholesale Industryreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥66.4bn |
| Medical Equipment Wholesale Industryreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥65.9bn |
| Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥490m |
| Medical Equipment Wholesale Industryreportable segment | segment assets | at 2023-03-31 | ¥27.8bn |
| Medical Equipment Wholesale Industryreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.6bn |
| Nursing Industryreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥663m |
| Nursing Industryreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥171m |
| Nursing Industryreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.1bn |
| Nursing Industryreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.1bn |
| Nursing Industryreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥4m |
| Nursing Industryreportable segment | segment assets | at 2023-03-31 | ¥5.5bn |
| Nursing Industryreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥335m |
| Wholesaler Of Drugs Industryreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥953m |
| Wholesaler Of Drugs Industryreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥520m |
| Wholesaler Of Drugs Industryreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥187.2bn |
| Wholesaler Of Drugs Industryreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥178.6bn |
| Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥8.6bn |
| Wholesaler Of Drugs Industryreportable segment | segment assets | at 2023-03-31 | ¥89.7bn |
| Wholesaler Of Drugs Industryreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥274.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥262.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥12.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥174.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥4.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,876
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets per share (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 1986.27 | |
| Dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 17.00 | |
| Dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 15.00 | |
| Dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 17.00 | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 20.00 | |
| Dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 20.00 | |
| Interim dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 7.50 | |
| Interim dividend paid per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 7.50 | |
| Interim dividend paid per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 7.50 | |
| Interim dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 7.50 | |
| Interim dividend paid per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 10.00 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 8.70 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 27.33 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 27.27 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 52.36 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 15.39 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration_NonConsolidatedMember | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 0.9941 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 0.9650 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 0.9645 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.9676 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 0.9646 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 0.0051 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 0.0153 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.0144 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.0270 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 0.0078 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 81.72 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 27.62 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 24.21 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 12.09 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 56.54 | |
| Payout ratio (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 1.9540 | |
| Payout ratio (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 0.5489 | |
| Payout ratio (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 0.6234 | |
| Payout ratio (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 0.3820 | |
| Payout ratio (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 1.2996 | |
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 53 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 62 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 62 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 63 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 58 | |
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 25 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 25 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 28 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 28 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |